Tramadol

Half-Life (t½)
PO: 5.5h · IV: 5.5h
Formula
C16H25NO2
Molecular Weight
263.38 g/mol
PubChem CID
33741
Aliases
Ultram, ConZip

Pharmacological Mechanism

Weak µ-opioid agonist via CYP2D6-mediated conversion to O-desmethyltramadol (active metabolite with 200× µ-affinity vs parent). Parent compound is a serotonin + norepinephrine reuptake inhibitor — serotonergic load creates seizure + serotonin-syndrome risk. CYP2D6 polymorphism drives analgesia + respiratory depression variability.

Half-Life & Elimination Curve (PO: 5.5h · IV: 5.5h)

100%50%25%12.5%0%0h0×t½5.5h1×t½11h2×t½16.5h3×t½22h4×t½27.5h5×t½0×t½ (0h): 100% remaining (~0.187 mg/L)1×t½ (5.5h): 50% remaining (~93.6 µg/L)2×t½ (11h): 25% remaining (~46.8 µg/L)3×t½ (16.5h): 12.5% remaining (~23.4 µg/L)4×t½ (22h): 6.3% remaining (~11.7 µg/L)5×t½ (27.5h): 3.1% remaining (~5.85 µg/L)
Plasma (PO)t½ Decay (5.5h)Effect Site (ke0)
  • 0×t½0h100% (0.187 mg/L)
  • 1×t½5.5h50% (93.6 µg/L)
  • 2×t½11h25% (46.8 µg/L)
  • 3×t½16.5h12.5% (23.4 µg/L)
  • 4×t½22h6.3% (11.7 µg/L)
  • 5×t½27.5h3.1% (5.85 µg/L)
Elimination t½5.5h (PO)
Rate Constant (ke)0.126 h⁻¹
Time to Peak (Tmax)1.48h
Est. Peak (Cmax)0.187 mg/L
Clearance (CL)26.5 L/h
97% Washout (5×t½)27.5h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References